FDA panel gives cautious nod to the Watchman 3

The FDA’s Circulatory System Devices Panel voted 7-5 in favor of the Watchman, an implantable device that blocks the left atrial appendage with a fabric-covered expandable nitinol cage. It is designed to help patients with nonvalvular AF avoid warfarin therapy.

You can read a Heartwire story, a MedPage story, or a Reuters story.

You can read links to additonal coverage about the device in our previous story.

About these ads

3 comments

  1. Pingback: WATCHMAN: will it replace warfarin in some patients? « CardioBrief

  2. Pingback: FDA: Watchman device will need to wait a bit longer « CardioBrief

  3. Pingback: Late-Breaking News: Confusion Over ACC Late-Breaker Trial « CardioBrief

What do you think?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s